Are rich nations up for drug reform?

摘要

The global debate over the high cost of drugs reaches Geneva this month, when the governing body of the World Health Organization (WHO) will consider two proposals aimed at reshaping the forces that drive medical research and development. The proposals direct the WHO to act on two controversial issues: the lack of affordable, effective medicines for people in poor countries, and the international intellectual-property system that governs the distribution of medical treatments.